Sanofi has become the third company to announce the price cuts of up to 78 percent. Novo Nordisk and Eli Lilly have revealed similar reductions to their insulin prices.
Sanofi to cut US price of its most-prescribed insulin by 78% bworldonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bworldonline.com Daily Mail and Mail on Sunday newspapers.
Sanofi SA said late on Thursday it will cut US list prices for its most-prescribed insulin product, Lantus, by 78 per cent starting next year after similar..
Sanofi said on Thursday it will cut US list prices for its most-prescribed insulin product, Lantus, by 78% starting next year after similar moves by rivals Novo Nordisk and Eli Lilly.
For years, defenders of pharma patents loved to claim that the reason that they needed patents and the reason they had to charge extortionate rates for drugs was because of the high cost of R&D for new drugs. The numbers keep going up. When I first started covering pharma patents, the number bandied about was…